BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 21822310)

  • 1. 1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcoma.
    Mackintosh C; Ordóñez JL; García-Domínguez DJ; Sevillano V; Llombart-Bosch A; Szuhai K; Scotlandi K; Alberghini M; Sciot R; Sinnaeve F; Hogendoorn PC; Picci P; Knuutila S; Dirksen U; Debiec-Rychter M; Schaefer KL; de Álava E
    Oncogene; 2012 Mar; 31(10):1287-98. PubMed ID: 21822310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profiling of peripheral blood cells: new insights into Ewing sarcoma biology and clinical applications.
    Przybyl J; Kozak K; Kosela H; Falkowski S; Switaj T; Lugowska I; Szumera-Cieckiewicz A; Ptaszynski K; Grygalewicz B; Chechlinska M; Pienkowska-Grela B; Debiec-Rychter M; Siedlecki JA; Rutkowski P
    Med Oncol; 2014 Aug; 31(8):109. PubMed ID: 25008066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden.
    Peneder P; Stütz AM; Surdez D; Krumbholz M; Semper S; Chicard M; Sheffield NC; Pierron G; Lapouble E; Tötzl M; Ergüner B; Barreca D; Rendeiro AF; Agaimy A; Boztug H; Engstler G; Dworzak M; Bernkopf M; Taschner-Mandl S; Ambros IM; Myklebost O; Marec-Bérard P; Burchill SA; Brennan B; Strauss SJ; Whelan J; Schleiermacher G; Schaefer C; Dirksen U; Hutter C; Boye K; Ambros PF; Delattre O; Metzler M; Bock C; Tomazou EM
    Nat Commun; 2021 May; 12(1):3230. PubMed ID: 34050156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative gene network and functional analyses identify a prognostically relevant key regulator of metastasis in Ewing sarcoma.
    Cidre-Aranaz F; Li J; Hölting TLB; Orth MF; Imle R; Kutschmann S; Ammirati G; Ceranski K; Carreño-Gonzalez MJ; Kasan M; Marchetto A; Funk CM; Bestvater F; Bersini S; Arrigoni C; Moretti M; Thiel U; Baumhoer D; Sahm F; Pfister SM; Hartmann W; Dirksen U; Romero-Pérez L; Banito A; Ohmura S; Musa J; Kirchner T; Knott MML; Grünewald TGP
    Mol Cancer; 2022 Jan; 21(1):1. PubMed ID: 34980141
    [No Abstract]   [Full Text] [Related]  

  • 5. CRISPR-Cas9 knockout screening identifies KIAA1429 as an essential gene in Ewing sarcoma.
    Tan K; Lu W; Chen F; Shi H; Ma Y; Chen Z; Wu W; Lv Z; Mo J
    J Exp Clin Cancer Res; 2023 Sep; 42(1):250. PubMed ID: 37759224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative analyses of bulk microarray data to discover genes, pathways, and immune infiltration characteristics associated with targeting of Ewing sarcoma.
    Cao B; Sun H; Fan Z; Khawar MB; Cai L; Yu S; Liang Z; Lv D; Wang N; Bi C; Sun H
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):6967-6977. PubMed ID: 36849756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinformatic Analysis of Recurrent Genomic Alterations and Corresponding Pathway Alterations in Ewing Sarcoma.
    Rock A; Uche A; Yoon J; Agulnik M; Chow W; Millis S
    J Pers Med; 2023 Oct; 13(10):. PubMed ID: 37888109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complex/cryptic
    Zou YS; Morsberger L; Hardy M; Ghabrial J; Stinnett V; Murry JB; Long P; Kim A; Pratilas CA; Llosa NJ; Ladle BH; Lemberg KM; Levin AS; Morris CD; Haley L; Gocke CD; Gross JM
    Genes (Basel); 2023 May; 14(6):. PubMed ID: 37372318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatic Copy Number Alteration in Circulating Tumor DNA for Monitoring of Pediatric Patients with Cancer.
    Ruas JS; Silva FLT; Euzébio MF; Biazon TO; Daiggi CMM; Nava D; Franco MT; Cardinalli IA; Cassone AE; Pereira LH; Seidinger AL; Maschietto M; Jotta PY
    Biomedicines; 2023 Apr; 11(4):. PubMed ID: 37189699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and biologic biomarkers of Ewing sarcoma: A systematic review.
    Daher M; Zalaquett Z; Chalhoub R; Abi Farraj S; Abdo M; Sebaaly A; Kourie HR; Ghanem I
    J Bone Oncol; 2023 Jun; 40():100482. PubMed ID: 37180735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic multi-omics cell line profiling uncovers principles of Ewing sarcoma fusion oncogene-mediated gene regulation.
    Orth MF; Surdez D; Faehling T; Ehlers AC; Marchetto A; Grossetête S; Volckmann R; Zwijnenburg DA; Gerke JS; Zaidi S; Alonso J; Sastre A; Baulande S; Sill M; Cidre-Aranaz F; Ohmura S; Kirchner T; Hauck SM; Reischl E; Gymrek M; Pfister SM; Strauch K; Koster J; Delattre O; Grünewald TGP
    Cell Rep; 2022 Dec; 41(10):111761. PubMed ID: 36476851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of Metastasis in Ewing Sarcoma.
    Li M; Chen C
    Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma.
    Shulman DS; Whittle SB; Surdez D; Bailey KM; de Álava E; Yustein JT; Shlien A; Hayashi M; Bishop AJR; Crompton BD; DuBois SG; Shukla N; Leavey PJ; Lessnick SL; Kovar H; Delattre O; Grünewald TGP; Antonescu CR; Roberts RD; Toretsky JA; Tirode F; Gorlick R; Janeway KA; Reed D; Lawlor ER; Grohar PJ
    NPJ Precis Oncol; 2022 Sep; 6(1):65. PubMed ID: 36115869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of aberrantly methylated differentially expressed genes and pro-tumorigenic role of KIF2C in melanoma.
    Huang CH; Han W; Wu YZ; Shen GL
    Front Genet; 2022; 13():817656. PubMed ID: 35991567
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of DTL in Hepatocellular Carcinoma and Its Impact on the Tumor Microenvironment.
    Li Z; Wang R; Qiu C; Cao C; Zhang J; Ge J; Shi Y
    Front Immunol; 2022; 13():834606. PubMed ID: 35392073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective histone methyltransferase G9a inhibition reduces metastatic development of Ewing sarcoma through the epigenetic regulation of NEU1.
    García-Domínguez DJ; Hajji N; López-Alemany R; Sánchez-Molina S; Figuerola-Bou E; Morón Civanto FJ; Rello-Varona S; Andrés-León E; Benito A; Keun HC; Mora J; Tirado ÓM; de Álava E; Hontecillas-Prieto L
    Oncogene; 2022 Apr; 41(18):2638-2650. PubMed ID: 35354905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of DTL as Related Biomarker and Immune Infiltration Characteristics of Nasopharyngeal Carcinoma via Comprehensive Strategies.
    Wang H; Zhang J
    Int J Gen Med; 2022; 15():2329-2345. PubMed ID: 35264872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of DTL enhances cell motility and promotes tumor metastasis in cervical adenocarcinoma by inducing RAC1-JNK-FOXO1 axis.
    Liu S; Gu L; Wu N; Song J; Yan J; Yang S; Feng Y; Wang Z; Wang L; Zhang Y; Jin Y
    Cell Death Dis; 2021 Oct; 12(10):929. PubMed ID: 34635635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic and Transcriptomic Analysis of Relapsed and Refractory Childhood Solid Tumors Reveals a Diverse Molecular Landscape and Mechanisms of Immune Evasion.
    Byron SA; Hendricks WPD; Nagulapally AB; Kraveka JM; Ferguson WS; Brown VI; Eslin DE; Mitchell D; Cornelius A; Roberts W; Isakoff MS; Oesterheld JE; Wada RK; Rawwas J; Neville K; Zage PE; Harrod VL; Bergendahl G; VanSickle E; Dykema K; Bond J; Chou HC; Wei JS; Wen X; Reardon HV; Roos A; Nasser S; Izatt T; Enriquez D; Hegde AM; Cisneros F; Christofferson A; Turner B; Szelinger S; Keats JJ; Halperin RF; Khan J; Saulnier Sholler GL; Trent JM
    Cancer Res; 2021 Dec; 81(23):5818-5832. PubMed ID: 34610968
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.